A holistic view of the HPAPI opportunity
The High Potency Active Pharmaceutical Ingredients (HPAPI) segment is the potential cash cow of the pharma procurement basket but…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Beyond the Ban
The Government of India (GOI) recently banned the use of serology-based test kits for diagnosis of tuberculosis. But this will…
Sanofi ties up with Joslin Diabetes Center
Both parties will have access to intellectual property for internal research use
BoehringerLilly alliance to launch first diabetes drug in India
Boehringer Ingelheim India and Eli Lilly and Company India (Lilly), which represents the Boehringer Ingelheim – Lilly global…
CHMP recommends Novartis drug Afinitor for EU approval
To mark major milestone in the treatment of advanced breast cancer
Daiichi Sankyo and Ranbaxy launch hybrid business in Venezuela
The Venezuelan pharmaceutical market is the third largest in Latin America
COMP adopts recommendations for orphan designation
It also confirmed the orphan designation for Kalydeco
GoI bans use, import of blood test kits for TB
WHO had found that such kits give misleading results and could result in more harm than good
UNITAID approves $30 mn for TB test at reduced cost
The US Government and Bill & Melinda Gates Foundation will reduce the price of diagnostic cartridges from $17 to less than $10…
Public awareness on anorexia improving, but pharma industry still lacking ideas: GlobalData
A new molecule from Daiichi Sankyo, is set to change the scenario when it hits the Japanese market in 2014